Clustering Postsynaptic Proteins at Neuromuscular Synapses: From Dok-7 to Rapsyn
神经肌肉突触处的突触后蛋白聚集:从 Dok-7 到 Rapsyn
基本信息
- 批准号:8658160
- 负责人:
- 金额:$ 41.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-15 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgrinBindingBiochemicalBiochemical GeneticsBirthCellsCholinergic ReceptorsComplexCongenital Myasthenic SyndromesCytoskeletonDataDefectDiseaseFailureGenesGeneticHealthHumanIntegral Membrane ProteinIntercellular JunctionsLeadLigandsLinkMaintenanceMass Spectrum AnalysisMediatingMembrane ProteinsMotor NeuronsMovementMusMuscle FatigueMuscle FibersMuscle WeaknessMuscle-Specific KinaseMutationMyastheniaNerveNeurodegenerative DisordersNeuromuscular DiseasesNeurotransmitter ReceptorPTB DomainPathway interactionsPeripheralPhosphorylationPlayPostsynaptic MembraneProceduresProtein BindingProteinsRecruitment ActivityRoleSH3 DomainsSignal PathwaySignal TransductionSkeletal MuscleSynapsesSynaptic TransmissionTyrosineTyrosine PhosphorylationWorkadapter proteinagrin receptorclinically relevantcongenital neuromuscular disorderdesignmutantneuromuscularnovel therapeuticsperipheral membrane protein 43Kpostsynapticprogramsprotein complexprotein functionresearch studyscaffoldsrc Homology Region 2 Domainsynaptogenesis
项目摘要
The Agrin/Lrp4/MuSK/Dok-7 signal transduction cascade is critical for synaptogenesis. Binding between Agrin and Lrp4 stimulates tyrosine phosphorylation of MuSK and recruitment and tyrosine phosphorylation of Dok-7. Hypomorphic mutations in human Agrin, MuSK or Dok-7, which impair their function, cause congenital myasthenia, characterized by structurally and functionally defective synapses, leading to muscle weakness and fatigue, emphasizing the clinical relevance of this signaling pathway. Once phosphorylated, Dok-7 recruits Crk and Crk-L, two related adapter proteins. The Agrin/Lrp4/Dok-7/Crk/Crk-L signaling pathway ultimately intersects with the cytoskeleton to cause accumulation of AChRs and other proteins in the postsynaptic membrane. The experiments in this proposal are designed to reveal the molecules and mechanisms that link recruitment of Crk/Crk-L to the redistribution and anchoring of acetylcholine receptors (AChRs) at developing and adult synapses. The proposed experiments will identify proteins that associate with Rapsyn, an AChR-associated protein that is essential to cluster AChRs, and analyze how these newly identified synaptic proteins, including Vezatin, regulate synaptic differentiation. These studies are clinically relevant, as mutations in Agrin, MuSK, Dok-7 and Rapsyn cause congenital myasthenia, so understanding how these proteins work will contribute to a better understanding of these diseases and may lead to novel therapeutic strategies. Moreover, mutations in genes that are downstream from Crk/Crk-L may likewise cause congenital myasthenia, so identifying the pathway downstream from Crk/Crk-L may reveal new genes responsible for congenital myasthenia.
Agrin/LRP4/Musk/Dok-7信号转导级联对于突触发生至关重要。 Agrin和LRP4之间的结合刺激了麝香的酪氨酸磷酸化,DOK-7的募集和酪氨酸磷酸化。损害其功能的人Agrin,Musk或Dok-7中的肌肌肌动症,以结构和功能上有缺陷的突触,导致肌肉无力和疲劳,这会引起先天肌无力,从而强调了该信号通路的临床相关性。一旦磷酸化,DOK-7招募了两个相关的衔接蛋白CRK和CRK-L。 Agrin/LRP4/DOK-7/CRK/CRK/CRK-L信号通路最终与细胞骨架相交,导致ACHR和其他蛋白质在突触后膜中的积累。该提案中的实验旨在揭示将CRK/CRK-L募集到发育和成人突触中乙酰胆碱受体(ACHR)的重新分布和锚定的分子和机制。提出的实验将鉴定与RAPSYN相关的蛋白质,RAPSYN是一种与ACHR相关的蛋白质,对于聚集ACHR至关重要,并分析了这些新鉴定的突触蛋白(包括Vezatin)如何调节突触分化。这些研究在临床上具有相关性,因为Agrin,Musk,Dok-7和Rapsyn的突变会引起先天肌无力,因此了解这些蛋白质的工作将如何有助于更好地理解这些疾病,并可能导致新的治疗策略。此外,从CRK/CRK-L下游的基因突变也可能引起先天性肌无力,因此鉴定CRK/CRK-L下游的途径可能会揭示出负责先天性肌动脉粥样硬化的新基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven Burden其他文献
Steven Burden的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven Burden', 18)}}的其他基金
THE ROLE OF AGRIN/LRP4/MUSK/DOK-7 SIGNALING IN DISASSEMBLY OF NEUROMUSCULAR SYNAPSES DURING AGING.
AGRIN/LRP4/MUSK/DOK-7 信号在衰老过程中神经肌肉突触分解中的作用。
- 批准号:
9001539 - 财政年份:2015
- 资助金额:
$ 41.83万 - 项目类别:
Development and Homeostasis of Skeletal Muscle in Health and Disease
健康和疾病中骨骼肌的发育和稳态
- 批准号:
8982136 - 财政年份:2015
- 资助金额:
$ 41.83万 - 项目类别:
THE ROLE OF AGRIN/LRP4/MUSK/DOK-7 SIGNALING IN DISASSEMBLY OF NEUROMUSCULAR SYNAPSES DURING AGING.
AGRIN/LRP4/MUSK/DOK-7 信号在衰老过程中神经肌肉突触分解中的作用。
- 批准号:
9145624 - 财政年份:2015
- 资助金额:
$ 41.83万 - 项目类别:
Clustering Postsynaptic Proteins at Neuromuscular Synapses: From Dok-7 to Rapsyn
神经肌肉突触处突触后蛋白的聚集:从 Dok-7 到 Rapsyn
- 批准号:
8158617 - 财政年份:2011
- 资助金额:
$ 41.83万 - 项目类别:
Clustering Postsynaptic Proteins at Neuromuscular Synapses: From Dok-7 to Rapsyn.
神经肌肉突触处突触后蛋白的聚集:从 Dok-7 到 Rapsyn。
- 批准号:
8669301 - 财政年份:2011
- 资助金额:
$ 41.83万 - 项目类别:
Clustering Postsynaptic Proteins at Neuromuscular Synapses: From Dok-7 to Rapsyn
神经肌肉突触处的突触后蛋白聚集:从 Dok-7 到 Rapsyn
- 批准号:
8461165 - 财政年份:2011
- 资助金额:
$ 41.83万 - 项目类别:
Clustering Postsynaptic Proteins at Neuromuscular Synapses: From Dok-7 to Rapsyn
神经肌肉突触处突触后蛋白的聚集:从 Dok-7 到 Rapsyn
- 批准号:
8299515 - 财政年份:2011
- 资助金额:
$ 41.83万 - 项目类别:
相似国自然基金
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
- 批准号:82371373
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Agrin调控脑微血管周细胞线粒体自噬依赖性铁死亡的分子机制研究
- 批准号:82301501
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
细胞外基质Agrin在脑小血管病类淋巴系统功能障碍中的作用和机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
细胞外基质蛋白Agrin调控肌卫星细胞稳态及其参与老年肌少症发生的机制研究
- 批准号:82260287
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
细胞外基质Agrin在脑小血管病类淋巴系统功能障碍中的作用和机制
- 批准号:82271337
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
相似海外基金
Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy
使用反义寡核苷酸促进成人海马神经发生作为阿尔茨海默氏病的治疗
- 批准号:
10484703 - 财政年份:2022
- 资助金额:
$ 41.83万 - 项目类别:
Entrepreneurial development award for a novel Alzheimer's disease therapeutic
一种新型阿尔茨海默氏病治疗药物获得创业发展奖
- 批准号:
10515571 - 财政年份:2022
- 资助金额:
$ 41.83万 - 项目类别:
Promoting adult hippocampal neurogenesis in Alzheimer's Disease using an antibody-based therapy
使用基于抗体的疗法促进阿尔茨海默病的成人海马神经发生
- 批准号:
10325833 - 财政年份:2021
- 资助金额:
$ 41.83万 - 项目类别: